Differences of circulating inflammatory markers between large- and small vessel disease in patients with acute ischemic stroke

International Journal of Medical Sciences

Volumn 10, Issue 10, 2013, Pages 1399-1405

  Zeng, Lili ^a,b   He, Xiaosong ^b,c   Liu, Jianrong ^a   Wang, Ling ^a   Weng, Suiqing ^a   Wang, Yongting ^b,c   Chen, Shengdi ^a   Yang, Guo Yuan ^a,b,c  

^a SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

^b Neuroscience and Neuroengineering Research Center Med X Research Institute and School of Biomedical Engineering   (China)

^c SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

CRP; Cytokine; Inflammation; Stroke subtype

Indexed keywords

APOLIPOPROTEIN A; APOLIPOPROTEIN B; C REACTIVE PROTEIN; CD40 LIGAND; CHOLESTEROL; D DIMER; FIBRINOGEN; GAMMA INTERFERON; HIGH DENSITY LIPOPROTEIN; INTERLEUKIN 17; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; BIOLOGICAL MARKER; FIBRIN DEGRADATION PRODUCT; FIBRIN FRAGMENT D;

ADULT; AGED; ARTICLE; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; CARDIOEMBOLIC STROKE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; FEMALE; FIBRINOLYSIS; HUMAN; LARGE ARTERY ATHEROSCLEROSIS; LEUKOCYTE; LIPOPROTEIN BLOOD LEVEL; LYMPHOCYTE; MAJOR CLINICAL STUDY; MALE; PROTEIN BLOOD LEVEL; SMALL ARTERY OCCLUSION; STROKE PATIENT; TRIACYLGLYCEROL BLOOD LEVEL; BLOOD; CEREBROVASCULAR ACCIDENT; INFLAMMATION; METABOLISM; MIDDLE AGED;

AGED; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; FIBRINOGEN; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; STROKE;

EID: 84883171243     PISSN: 14491907     EISSN: None     Source Type: Journal    
DOI: 10.7150/ijms.6652     Document Type: Article

References (21)

1. Muir KW, Tyrrell P, Sattar N, Warburton E. Inflammation and ischaemic stroke. Curr Opin Neurol. 2007; 20: 334-42. doi:10.1097/WCO.0b013e32813ba15100019052-200706000-00016 [pii].
2. Lambertsen KL, Biber K, Finsen B. Inflammatory cytokines in experimental and human stroke. J Cereb Blood Flow Metab. 2012; 32: 1677-98. doi:jcbfm201288 [pii]10.1038/jcbfm.2012.88.
3. Tuttolomondo A, Di Raimondo D, di Sciacca R, Pinto A, Licata G. Inflammatory cytokines in acute ischemic stroke. Curr Pharm Des. 2008; 14: 3574-89.
4. Basic Kes V, Simundic AM, Nikolac N, Topic E, Demarin V. Pro-inflammatory and anti-inflammatory cytokines in acute ischemic stroke and their relation to early neurological deficit and stroke outcome. Clin Biochem. 2008; 41: 1330-4. doi:S0009-9120(08)00379-2 [pii]10.1016/j.clinbiochem.2008.08.080.
5. Tuttolomondo A, Di Raimondo D, Pecoraro R, Arnao V, Pinto A, Licata G. Inflammation in ischemic stroke subtypes. Curr Pharm Des. 2012; 18: 4289-310. doi:CPD-EPUB-20120229-002 [pii].
6. Beer C, Blacker D, Hankey GJ, Puddey IB. Association of clinical and aetiologic subtype of acute ischaemic stroke with inflammation, oxidative stress and vascular function: a cross-sectional observational study. Med Sci Monit. 2011; 17: CR467-73. doi:881931 [pii].
7. Rao R, Tah V, Casas JP, Hingorani A, Whittaker J, Smeeth L, et al. Ischaemic stroke subtypes and their genetic basis: a comprehensive meta-analysis of small and large vessel stroke. Eur Neurol. 2009; 61: 76-86. doi:000177939 [pii]10.1159/000177939.
8. Brisset M, Boutouyrie P, Pico F, Zhu Y, Zureik M, Schilling S, et al. Large-vessel correlates of cerebral small-vessel disease. Neurology. 2013; 80: 662-9. doi:WNL.0b013e318281ccc2[pii]10.1212/WNL. 0b013e318281ccc2.
9. Jung KW, Shon YM, Yang DW, Kim BS, Cho AH. Coexisting carotid atherosclerosis in patients with intracranial small-or large-vessel disease. J Clin Neurol. 2012; 8: 104-8. doi:10.3988/jcn.2012.8.2.104.
10. Adams HP, Jr., Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke. 1993; 24: 35-41.
11. Sims JR, Gharai LR, Schaefer PW, Vangel M, Rosenthal ES, Lev MH, et al. ABC/2 for rapid clinical estimate of infarct, perfusion, and mismatch volumes. Neurology. 2009; 72: 2104-10. doi:72/24/2104 [pii]10.1212/WNL.0b013e3181aa5329.
12. Di Napoli M, Schwaninger M, Cappelli R, Ceccarelli E, Di Gianfilippo G, Donati C, et al. Evaluation of C-reactive protein measurement for assessing the risk and prognosis in ischemic stroke: a statement for health care professionals from the CRP Pooling Project members. Stroke, a journal of cerebral circulation. 2005; 36: 1316-29. doi:10.1161/01.STR.0000165929.78756.ed.
13. Seo WK, Seok HY, Kim JH, Park MH, Yu SW, Oh K, et al. C-Reactive protein is a predictor of early neurologic deterioration in acute ischemic stroke. Journal of stroke and cerebrovascular diseases: the official journal of National Stroke Association. 2012; 21: 181-6. doi:10.1016/j.jstrokecerebrovasdis.2010.06.002.
14. Chan CP, Jiang HL, Leung LY, Wan WM, Cheng NM, Ip WS, et al. Multiple atherosclerosis-related biomarkers associated with short-and long-term mortality after stroke. Clinical biochemistry. 2012; 45: 1308-15. doi:10.1016/j.clinbiochem.2012.06.014.
15. Dewan KR, Rana PV. C-reactive protein and early mortality in acute ischemic stroke. Kathmandu Univ Med J (KUMJ). 2011; 9: 252-5.
16. Hamidon BB, Sapiah S, Nawawi H, Raymond AA. The prognostic value of C-reactive protein (CRP) levels in patients with acute ischaemic stroke. The Medical journal of Malaysia. 2004; 59: 631-7.
17. Yu Q, Lin Y, Yang P, Wang Y, Zhao S, Fan J, et al. C-reactive protein is associated with the progression of acute embolic stroke in rabbit model. Journal of thrombosis and thrombolysis. 2012; 33: 301-7. doi:10.1007/s11239-011-0627-0.
18. Ladenvall C, Jood K, Blomstrand C, Nilsson S, Jern C, Ladenvall P. Serum C-reactive protein concentration and genotype in relation to ischemic stroke subtype. Stroke, a journal of cerebral circulation. 2006; 37: 2018-23. doi:10.1161/01.STR.0000231872.86071.68.
19. Vibo R, Korv J, Roose M, Kampus P, Muda P, Zilmer K, et al. Acute phase proteins and oxidised low-density lipoprotein in association with ischemic stroke subtype, severity and outcome. Free radical research. 2007; 41: 282-7. doi:10.1080/10715760601083235.
20. Andersson J, Johansson L, Ladenvall P, Wiklund PG, Stegmayr B, Jern C, et al. C-reactive protein is a determinant of first-ever stroke: prospective nested case-referent study. Cerebrovasc Dis. 2009; 27: 544-51. doi:10.1159/000214217.
21. Krupinski J, Turu MM, Slevin M, Martinez-Gonzalez J. Carotid plaque, stroke pathogenesis, and CRP: treatment of ischemic stroke. Current treatment options in cardiovascular medicine. 2007; 9: 229-35.